Ovarian Cancer Institute Inc is located in Atlanta, GA. The organization was established in 1999. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ovarian Cancer Institute Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Ovarian Cancer Institute Inc generated $777.0k in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 10.1% each year . All expenses for the organization totaled $848.8k during the year ending 12/2021. While expenses have increased by 9.8% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE OVARIAN CANCER INSTITUTE DEVELOPS INNOVATIVE RESEARCH FOR EARLY DETECTION AND MORE EFFECTIVE TREATMENT OF CANCER, PROVIDES EDUCATIONAL OPPORTUNITIES FOR MEDICAL PROFESSIONALS, EDUCATES AND HEIGHTENS AWARENESS OF OVARIAN CANCER SYMPTOMS AND THEIR TREATMENT OPTIONS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE OVARIAN CANCER INSTITUTE COMPILED RESEARCH ON DETECTING MORE EFFECTIVE TREATMENT OF CANCER, PROVIDED OPPORTUNITIES FOR MEDICAL PROFESSIONALS, AND HELD SEMINARS TO EDUCATE WOMEN ON POSSIBLE SYMPTOMS OF OVARIAN CANCER AND ITS TREATMENT. OCI FUNDED RESEARCH ACCOMPLISHMENTS FOR 2021 INCLUDE: - INCREASED ACCURACY OF A STAGE I DIAGNOSTIC TEST FOR OVARIAN CANCER. - INCREASED ACCURACY OF DRUG PREDICTIVE ALGORITHM TO 80-90%. - COMPLETED PRE-CLINICAL STUDY OF NANOPARTICLE DRUG DELIVERY.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Kathryn Harper Executive Di | Officer | 40 | $107,000 |
Benedict Benigno CEO | Officer | 8 | $45,000 |
Hillyer Young Chairman | OfficerTrustee | 2 | $0 |
Amanda Sills Secretary | OfficerTrustee | 1 | $0 |
Becca Krumdieck Treasurer | OfficerTrustee | 2 | $0 |
Dana Whitlow Golf Chairma | OfficerTrustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $78,638 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $560,683 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $639,321 |
Total Program Service Revenue | $0 |
Investment income | $420 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $137,298 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $777,039 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $641,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $152,000 |
Compensation of current officers, directors, key employees. | $36,600 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $3,000 |
Payroll taxes | $8,186 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $925 |
Office expenses | $8,954 |
Information technology | $880 |
Royalties | $0 |
Occupancy | $4,248 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $59 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $3,969 |
All other expenses | $3,417 |
Total functional expenses | $848,829 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $460,635 |
Savings and temporary cash investments | $150,178 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $610,813 |
Accounts payable and accrued expenses | $853 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $21,575 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $22,428 |
Net assets without donor restrictions | $588,385 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $610,813 |
Over the last fiscal year, we have identified 8 grants that Ovarian Cancer Institute Inc has recieved totaling $59,805.
Awarding Organization | Amount |
---|---|
Community Foundation Of West Georgia Inc Carrollton, GA PURPOSE: PROGRAM | $25,000 |
Goldman Sachs Philanthropy Fund New York, NY PURPOSE: MEDICAL / PUBLIC SERVICES | $10,000 |
Billi Marcus Foundation Inc Atlanta, GA PURPOSE: GENERAL OPERATIONS | $10,000 |
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $5,145 |
James D Magnus And Diane S Magnus Foundation Gainesville, GA PURPOSE: RESEARCH CANCER TREATMENT FOR OVARIAN CANCER | $5,000 |
Williams Family Foundation Falls Church, VA PURPOSE: MEDICAL RESEARCH | $2,500 |
Organization Name | Assets | Revenue |
---|---|---|
Miami Cancer Institute At Baptist Health Inc Coral Gables, FL | $26,197,765 | $83,763,407 |
Trenton Medical Center Inc High Springs, FL | $64,420,086 | $51,939,000 |
Guardian Research Network Inc Spartanburg, SC | $5,064,822 | $10,301,125 |
Glen Flora Lumberton, NC | $5,677,360 | $5,941,472 |
Walker Cancer Research Institute Inc Boynton Beach, FL | $8,994,408 | $4,172,874 |
Southeast Clinical Oncology Research Consortium Inc Winstonsalem, NC | $1,482,173 | $3,901,035 |
Ronald Mcdonald House Charities Of Memphis Inc Memphis, TN | $25,416,874 | $3,684,444 |
Liga Contra El Cancer Inc League Against Cancer Inc Miami, FL | $7,622,962 | $2,862,537 |
Camp Sunshine Inc Decatur, GA | $16,568,676 | $3,692,986 |
Force-Facing Our Risk Of Cancer Empowered Tampa, FL | $2,528,363 | $2,341,227 |
United Cancer Support Foundation Knoxville, TN | $495,054 | $1,929,700 |
Ceo Roundtable On Cancer Inc Morrisville, NC | $3,714,363 | $3,030,282 |